Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,500
Closed -$211K 1068
2026
Q1
$211K Buy
+7,500
New +$200K 0.01% 702
2025
Q3
Sell
-265,000
Closed -$6.42M 912
2025
Q2
$6.42M Buy
+265,000
New +$6.18M 0.17% 85

Other funds holding PFE

SIG Brokerage's PFE Position: Q2 2026 in Review

SIG Brokerage increased its Pfizer (PFE) stake by 70% in Q2 2026, buying an estimated $558K and bringing the position to 52,022 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #423.

SIG Brokerage first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.42M in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SIG Brokerage held 52,022 shares of Pfizer worth $1.25M as of Q2 2026.
  • SIG Brokerage bought 21,336 Pfizer shares in Q2 2026, an estimated $558K.
  • Pfizer made up 0.02% of SIG Brokerage's portfolio in Q2 2026, its #423 holding.
  • SIG Brokerage first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • SIG Brokerage's Pfizer position peaked at $2.42M in Q1 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.